Clinical Trial Update: Combined PSMA PET/MRI for Detection of Lymph Node Metastases in High-risk Prostate Cancer Patients [NA]

View source ↗

Summary

Clinical trial update on a study using combined PSMA PET/MRI to detect lymph node metastases in high-risk prostate cancer patients. The study status is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Norwegian University of Science and Technology | Conditions: Prostatic Neoplasms, Neoplasm Metastasis | NA | Status: COMPLETED